Author: Phil Prime

Cancer Research Matters provokes conversation around cancer science, how it shapes our understanding of the disease and the challenges we face as we develop therapies.

We hear how CRUK researchers got on at the Eureka international course on translational medicine in Sicily.

Restricting cancer cells of specific amino acids can slow tumour growth and sharpen the effects of chemotherapy and radiotherapy – now, startup Faeth Therapeutics is creating precision diets which can enhance cancer treatments.

In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research.

Cancer Research Matters provokes conversation around cancer science, how it shapes our understanding of the disease and the challenges we face as we develop therapies.

It’s clear genomics will be at the heart of future healthcare provision. That is especially true of cancer care –…

In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research.

We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs.

In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research.

What is extrachromosomal DNA? How have we come to think of its role in cancer? And what has all this got to do with a flagship lung cancer study?